Related references
Note: Only part of the references are listed.Stress-induced precocious aging in PD-patient iPSC-derived NSCs may underlie the pathophysiology of Parkinson's disease
Liang Zhu et al.
CELL DEATH & DISEASE (2019)
Identification of novel risk loci, causal insights, and heritable risk for Parkinson's disease: a meta-analysis of genome-wide association studies
Mike A. Nalls et al.
LANCET NEUROLOGY (2019)
Moving beyond neurons: the role of cell type-specific gene regulation in Parkinson's disease heritability
Regina H. Reynolds et al.
NPJ PARKINSONS DISEASE (2019)
Prenatal exposure to oxidative phosphorylation xenobiotics and late-onset Parkinson disease
Eldris Iglesias et al.
AGEING RESEARCH REVIEWS (2018)
Parkinson's disease genetic risk in a midbrain neuronal cell line
Steven E. Pierce et al.
NEUROBIOLOGY OF DISEASE (2018)
On Cell Loss and Selective Vulnerability of Neuronal Populations in Parkinson's Disease
Nicolas Giguere et al.
FRONTIERS IN NEUROLOGY (2018)
Enrichment of risk SNPs in regulatory regions implicate diverse tissues in Parkinson's disease etiology
Simon G. Coetzee et al.
SCIENTIFIC REPORTS (2016)
The Parkinson Disease gene SNCA: Evolutionary and structural insights with pathological implication
Irum Javaid Siddiqui et al.
SCIENTIFIC REPORTS (2016)
How to make a midbrain dopaminergic neuron
Ernest Arenas et al.
DEVELOPMENT (2015)
Aberrant epigenome in iPSC-derived dopaminergic neurons from Parkinson's disease patients
Ruben Fernandez-Santiago et al.
EMBO MOLECULAR MEDICINE (2015)
Genetic control of midbrain dopaminergic neuron development
Sandra Blaess et al.
WILEY INTERDISCIPLINARY REVIEWS-DEVELOPMENTAL BIOLOGY (2015)
The intriguing complexities of mammalian gene regulation: How to link enhancers to regulated genes. Are we there yet?
Bence Daniel et al.
FEBS LETTERS (2014)
Genetic Correction of a LRRK2 Mutation in Human iPSCs Links Parkinsonian Neurodegeneration to ERK-Dependent Changes in Gene Expression
Peter Reinhardt et al.
CELL STEM CELL (2013)
Endogenous alpha-synuclein influences the number of dopaminergic neurons in mouse substantia nigra
Pablo Garcia-Reitboeck et al.
EXPERIMENTAL NEUROLOGY (2013)
Disease-specific phenotypes in dopamine neurons from human iPS-based models of genetic and sporadic Parkinson's disease
Adriana Sanchez-Danes et al.
EMBO MOLECULAR MEDICINE (2012)
Progressive degeneration of human neural stem cells caused by pathogenic LRRK2
Guang-Hui Liu et al.
NATURE (2012)
Effects of Two Commonly Found Strains of Influenza A Virus on Developing Dopaminergic Neurons, in Relation to the Pathophysiology of Schizophrenia
Fernando Landreau et al.
PLOS ONE (2012)
Pharmacological Rescue of Mitochondrial Deficits in iPSC-Derived Neural Cells from Patients with Familial Parkinson's Disease
Oliver Cooper et al.
SCIENCE TRANSLATIONAL MEDICINE (2012)
Genetics of Parkinson's Disease
Christine Klein et al.
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2012)
Association of transcription factor polymorphisms PITX3 and EN1 with Parkinson's disease
Dietrich Haubenberger et al.
NEUROBIOLOGY OF AGING (2011)
Neuroprotective Upregulation of Endogenous Alpha-Synuclein Precedes Ubiquitination in Cultured Dopaminergic Neurons
R. E. J. Musgrove et al.
NEUROTOXICITY RESEARCH (2011)
SNCA Triplication Parkinson's Patient's iPSC-derived DA Neurons Accumulate α-Synuclein and Are Susceptible to Oxidative Stress
Blake Byers et al.
PLOS ONE (2011)
Clinical Progression in Parkinson Disease and the Neurobiology of Axons
Hsiao-Chun Cheng et al.
ANNALS OF NEUROLOGY (2010)
Lmx1a and Lmx1b cooperate with Foxa2 to coordinate the specification of dopaminergic neurons and control of floor plate cell differentiation in the developing mesencephalon
Tomoya Nakatani et al.
DEVELOPMENTAL BIOLOGY (2010)
Interactions of Wnt/β-Catenin Signaling and Sonic Hedgehog Regulate the Neurogenesis of Ventral Midbrain Dopamine Neurons
Mianzhi Tang et al.
JOURNAL OF NEUROSCIENCE (2010)
Gene-environment interactions in Parkinson's disease and other forms of parkinsonism
Jeffery M. Vance et al.
NEUROTOXICOLOGY (2010)
Foxa1 and Foxa2 function both upstream of and cooperatively with Lmx1a and Lmx1b in a feedforward loop promoting mesodiencephalic dopaminergic neuron development
Wei Lin et al.
DEVELOPMENTAL BIOLOGY (2009)
Morphometry of the human substantia nigra in ageing and Parkinson's disease
Gay Rudow et al.
ACTA NEUROPATHOLOGICA (2008)
Anterior-posterior graded response to Otx2 controls proliferation and differentiation of dopaminergic progenitors in the ventral mesencephalon
Daniela Omodei et al.
DEVELOPMENT (2008)
Age-associated increases of alpha-synuclein in monkeys and humans are associated with nigrostriatal dopamine depletion: Is this the target for Parkinson's disease?
Yaping Chu et al.
NEUROBIOLOGY OF DISEASE (2007)
Alpha-synuclein is upregulated in neurones in response to chronic oxidative stress and is associated with neuroprotection
M. C. Quilty et al.
EXPERIMENTAL NEUROLOGY (2006)
Evidence for specific phases in the development of human neuromelanin
H Fedorow et al.
NEUROBIOLOGY OF AGING (2006)
Ageing and the brain
R Peters
POSTGRADUATE MEDICAL JOURNAL (2006)
Progressive dopamine neuron loss in Parkinson's disease: The multiple hit hypothesis
Paul M. Carvey et al.
CELL TRANSPLANTATION (2006)
A common NURR1 polymorphism associated with Parkinson disease and diffuse Lewy body disease
KN Zheng et al.
ARCHIVES OF NEUROLOGY (2003)
Ageing of substantia nigra in humans: cell loss may be compensated by hypertrophy
CR Cabello et al.
NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY (2002)
Dopamine neurons derived from embryonic stem cells function in an animal model of Parkinson's disease
JH Kim et al.
NATURE (2002)
In utero bacterial endotoxin exposure causes loss of tyrosine hydroxylase neurons in the postnatal rat midbrain
ZD Ling et al.
MOVEMENT DISORDERS (2002)
Share Paper
